glycyrrhizic acid has been researched along with Chronic Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (24.00) | 18.7374 |
| 1990's | 10 (40.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, D; Hu, Z; Li, Y; Lv, H; Ma, S; Qu, J; Ren, J; Tang, W; Wang, Y; Xu, S; Yan, J; Yu, S | 1 |
| Agger, S; Murphy, SC; Rainey, PM | 1 |
| Cai, X; Cao, AP; Chen, CW; Chen, HZ; Chen, Y; Chen, YG; Fu, QC; Li, J; Lu, LG; Mao, YM; Sui, YH; Sun, Y; Wu, SM; Zeng, MD; Zhao, W | 1 |
| Barrientos, RM; Jekich, BM; Maier, SF; Milligan, ED; Schoeniger, D; Sloane, EM; Spataro, LE; Watkins, LR; Wieseler-Frank, J | 1 |
| Levy, C; Lindor, KD; Seeff, LD | 1 |
| Brinckmann, J; Bub, S; Cicconetti, G; Valentine, B | 1 |
| Iizuka, S; Imamura, S; Inoue, M; Makino, T; Mizukami, H; Ohtake, N; Tsuchiya, N; Watanabe, A | 1 |
| Wang, JT | 1 |
| Chen, HM; Han, DW; Jiang, CF; Liu, JH; Ma, XH; Su, XS; Wang, LH; Zhao, MQ; Zhao, YC | 1 |
| Ikeda, K; Koyake, E; Kumada, H; Yoshiba, A; Yoshida, Y | 1 |
| Abe, Y; Kato, T; Kohli, Y; Ueda, T | 1 |
| Arai, K; Okuno, T; Shindo, M | 1 |
| Kameyama, T; Nagao, Y; Sata, M; Tanikawa, K | 1 |
| Hino, K; Niwa, H; Sainokami, S | 1 |
| Aikawa, T; Iga, T; Kotaki, H; Osuga, T; Santa, T; Sawada, Y; Tanaka, N; Uchino, K; Yamamura, Y | 1 |
| Kiriyama, S; Kumada, T; Nakano, S; Osada, T; Samori, T; Shimada, S; Sugiyama, K; Takahashi, M; Takeda, I; Toyoda, H | 1 |
| Da Nagao, Y; Itoh, K; Kameyama, T; Sata, M; Suzuki, H; Tanikawa, K | 1 |
| Benner, K; Flora, K; Stolpman, D | 1 |
| Fujii, N; Harada, M; Kiura, K; Matsuo, K; Shimomura, H; Shinagawa, K; Takenaka, K | 1 |
| Kumada, H | 1 |
| Kageyama, Y | 1 |
| Kageyama, Y; Saruta, T; Suzuki, H | 1 |
| Hayashi, J; Ikematsu, H; Kashiwagi, S; Motomura, M; Noguchi, A; Tsuda, H; Tsuji, Y | 1 |
| Arima, T; Nagashima, H; Wada, T | 1 |
| Chaine, G; Fischbein, L; Garnier-Fabre, A; Paquet, R; Robert, N; Robineau, M | 1 |
2 review(s) available for glycyrrhizic acid and Chronic Disease
| Article | Year |
|---|---|
Use of herbal supplements for chronic liver disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chronic Disease; Drug Combinations; Drugs, Chinese Herbal; Glycyrrhizic Acid; Humans; Liver Diseases; Phytotherapy; Plant Extracts; Plants, Medicinal; Silymarin | 2004 |
[Therapy of chronic hepatitis other than interferon therapy].
Topics: Antiviral Agents; Chronic Disease; Drugs, Chinese Herbal; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis; Humans; Interleukin-2; Prednisolone; Ribavirin; Vidarabine | 1994 |
5 trial(s) available for glycyrrhizic acid and Chronic Disease
| Article | Year |
|---|---|
[Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study].
Topics: Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chronic Disease; Double-Blind Method; Fatty Liver; Female; Glycyrrhizic Acid; Humans; Injections, Intravenous; Liver; Liver Diseases; Liver Diseases, Alcoholic; Male; Saponins; Triterpenes | 2009 |
Efficacy of an herbal dietary supplement (Smooth Move) in the management of constipation in nursing home residents: A randomized, double-blind, placebo-controlled study.
Topics: Beverages; Chronic Disease; Cinnamomum aromaticum; Citrus sinensis; Constipation; Coriandrum; Defecation; Dietary Supplements; Double-Blind Method; Female; Foeniculum; Fruit; Glycyrrhizic Acid; Gum Arabic; Humans; Male; Nursing Homes; Pennsylvania; Phytotherapy; Plant Bark; Risk Factors; Treatment Outcome; Zingiber officinale | 2006 |
[A double-blind study of strong neominophagen-C in treating chronic hepatitis].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Cysteine; Double-Blind Method; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Hepatitis; Humans; Male; Oleanolic Acid; Plants, Medicinal | 1984 |
[Efficacy of interferon combined glycyrrhizin therapy in patients with interferon-resistant chronic hepatitis C].
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; Drug Resistance; Drug Therapy, Combination; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged | 1995 |
Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection.
Topics: Adult; Aged; Antiviral Agents; Chronic Disease; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Injections, Intravenous; Lichen Planus, Oral; Male; Middle Aged; Probability; Treatment Outcome | 1996 |
18 other study(ies) available for glycyrrhizic acid and Chronic Disease
| Article | Year |
|---|---|
Synthesis, biological evaluation, and molecular modeling of glycyrrhizin derivatives as potent high-mobility group box-1 inhibitors with anti-heart-failure activity in vivo.
Topics: Acute Disease; Animals; Cell Line; Chronic Disease; Doxorubicin; Glycyrrhizic Acid; Heart Failure; HMGB1 Protein; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Docking Simulation; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2013 |
Too much of a good thing: a woman with hypertension and hypokalemia.
Topics: Aldosterone; Chronic Disease; Dietary Supplements; Female; Glycyrrhiza; Glycyrrhizic Acid; Humans; Hypertension; Hypokalemia; Middle Aged; Potassium; Renin | 2009 |
Spinal gap junctions: potential involvement in pain facilitation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Carbenoxolone; Chronic Disease; Gap Junctions; Glycyrrhizic Acid; HIV Envelope Protein gp120; Hyperalgesia; Injections, Spinal; Interleukin-1; Male; Nerve Compression Syndromes; Pain; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Specific Pathogen-Free Organisms | 2004 |
Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury.
Topics: Administration, Oral; Animals; ATP-Binding Cassette Transporters; Chronic Disease; Disease Models, Animal; Down-Regulation; Glycyrrhizic Acid; Immunohistochemistry; Infusions, Intravenous; Liver; Male; Rats; Rats, Wistar | 2008 |
Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis.
Topics: Acute Disease; Adolescent; Adult; Animals; Antiviral Agents; Chronic Disease; Fatty Liver; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis, Viral, Animal; Hepatitis, Viral, Human; Humans; Liver Cirrhosis, Experimental; Male; Middle Aged; Rats; Rats, Inbred Strains | 1984 |
[Study on frequency of the eAg-eAb seroconversion by corticosteroid and glycyrrhizin in eAg positive chronic hepatitis (author's transl)].
Topics: Adrenal Cortex Hormones; Antibodies, Viral; Chronic Disease; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Humans | 1981 |
[Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C].
Topics: Adult; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Interferons; Male; Middle Aged | 1994 |
A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Chronic Disease; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Infusions, Intravenous; Lichen Planus, Oral; Male; Middle Aged | 1995 |
Pharmacokinetic profiles of glycyrrhizin in patients with chronic hepatitis.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Chronic Disease; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis; Humans; Injections, Intravenous; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged | 1993 |
[The pharmacokinetics of the glycyrrhizin and glycyrrhetic acid after intravenous administration of glycyrrhizin for the patients with chronic liver disease caused by type C hepatitis virus].
Topics: Aged; Antiviral Agents; Chronic Disease; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis C; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged | 1995 |
A cautionary note regarding glycyrrhiza (licorice root)
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Contraindications; Glycyrrhizic Acid; Humans; Hypertension, Portal; Liver Diseases | 1999 |
Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma.
Topics: Anti-HIV Agents; Antineoplastic Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Glycyrrhizic Acid; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Testicular Neoplasms; Virus Activation | 2001 |
Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.
Topics: Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Chronic Disease; Glycyrrhizic Acid; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Survival Analysis | 2002 |
A case of pseudoaldosteronism induced by glycyrrhizin.
Topics: Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis; Humans; Hyperaldosteronism; Male; Middle Aged; Renin | 1992 |
Renin-dependency of glycyrrhizin-induced pseudoaldosteronism.
Topics: Adult; Alanine Transaminase; Aldosterone; Aspartate Aminotransferases; Blood Pressure; Catecholamines; Chronic Disease; Epinephrine; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis; Humans; Male; Middle Aged; Norepinephrine; Potassium; Prospective Studies; Renin | 1991 |
Combination therapy of glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Chronic Disease; DNA-Directed DNA Polymerase; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B Antigens; Hepatitis B Surface Antigens; Humans; Interferon-gamma; Male; Middle Aged | 1989 |
Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.
Topics: Adult; Carcinoma, Hepatocellular; Chronic Disease; Cytotoxicity, Immunologic; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Humans; Interferon Type I; Killer Cells, Natural; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Picibanil; Radioimmunoassay; Skin Tests; Vidarabine | 1987 |
[Hypertensive retinopathy and papilledema. Apropos of a case of glycyrrhizin poisoning].
Topics: Adult; Chronic Disease; Fluorescein Angiography; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Hypertension; Male; Papilledema; Retinal Diseases | 1987 |